Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Neoantigen-targeted ppDC |
| Synonyms | |
| Therapy Description |
Limited information is currently available on neoantigen-targeted ppDC, a putative dendritic cell vaccine (Apr 2024). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Neoantigen-targeted ppDC | Limited information is currently available on neoantigen-targeted ppDC, a putative dendritic cell vaccine (Apr 2024). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06342908 | Phase I | Neoantigen-targeted ppDC Poly ICLC | A Vaccine (Neoantigen-Targeted ppDC) for the Treatment of H3 G34-mutant Diffuse Hemispheric Glioma | Recruiting | USA | 0 |